Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes - Takeaways - MDSpire

Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes

  • By

  • Afroditi Roumpou

  • Andrea Palermo

  • Symeon Tournis

  • Valeria Hasenmajer

  • Janice L Pasieka

  • Gregory Kaltsas

  • Andrea Isidori

  • Eva Kassi

  • April 3, 2025

  • 0 min

Share

  • 1

    Parathyroid disorders significantly affect bone metabolism, leading to various skeletal abnormalities due to altered calcium and phosphate homeostasis.

  • 2

    Hyperparathyroidism results in increased bone turnover and resorption, often leading to decreased bone mineral density and fragility fractures.

  • 3

    Successful parathyroidectomy can reverse skeletal defects in hyperparathyroidism, while calcimimetics and antiresorptive agents serve as alternatives.

  • 4

    Hypoparathyroidism causes low bone turnover and increased bone mineral density, but can lead to compromised bone strength and higher fracture risk.

  • 5

    Recombinant human PTH is effective for hypoparathyroidism but is reserved for refractory cases, with calcium and vitamin D as first-line treatments.

Original Source(s)

Related Content